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Aims: There is limited knowledge about the association of lipoprotein particles and markers of coronary atherosclerosis such as coronary artery calcification (CAC) in relatively young high-risk persons. This study examines
the association of lipoprotein subfractions and CAC in high cardiometabolic risk individuals.
Methods: The study presents analysis from baseline data of a randomized trial targeted at high-risk workers.
Employees of Baptist Health South Florida with metabolic syndrome or diabetes were recruited. At baseline, all
182 participants had lipoprotein subfraction analysis using the ion mobility technique and participants above 35
years (N = 170) had CAC test done. Principal components (PC) were computed for the combination of lipoprotein subclasses. Multiple bootstrapped regression analyses (BSA) were conducted to assess the relationship
between lipoprotein subfractions and CAC.
Results: The study population (N = 170) was largely female (84%) with a mean age of 58 years. Three PCs
accounted for 88% variation in the sample. PC2, with main contributions from VLDL particles in the positive
direction and large LDL particles in the negative direction was associated with a 22% increase in CAC odds (P
value ＜ 0.05 in 100% of BSA). PC3, with main contributions from HDL lipoprotein particles in the positive
direction and small/medium LDL and large IDL particles in the negative direction, was associated with a 9%
reduction in CAC odds (P ＜ 0.05 in 88% of BSA). PC1, which had approximately even contributions from
HDL, LDL, IDL and VLDL lipoprotein subfractions in the positive direction, was not associated with CAC.
Conclusion: In a relatively young but high-risk population, a lipoprotein profile predominated by triglyceriderich lipoproteins was associated with increased risk of CAC, while one predominated by HDL lipoproteins offered
modest protection. Lipoprotein sub-fraction analysis may help to further discriminate patients who require more
intensive cardiovascular work-up and treatment.
Key words: Lipoprotein Subfractions, Ion-Mobility, Coronary Atherosclerosis, Principal Component Analysis,
CVD risk stratification

Introduction
Coronary artery disease remains a major cause of
cardiovascular disease (CVD) morbidity and mortality. Due to the significant clinical, public health and
50

economic burden of coronary disease, atherosclerotic
CVD risk assessment is often conducted in asymptomatic adults visiting their primary care providers in
order to direct preventive care. Plasma low density lipoprotein cholesterol (LDL-C), high density lipoprotein
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cholesterol (HDL-C) and triglycerides are traditionally used to assess dyslipidemic burden and guide CVD
risk assessment and management. However, the use of
traditional lipids in CVD risk assessment is flawed by
its inability to identify young persons and women with
high atherosclerotic burden and thus missing early treatment opportunities in these individuals 1).
Non-invasive measures of coronary atherosclerosis such as coronary artery calcification (CAC) have
prognostic significance, are useful in cardiovascular disease risk stratification and are included in the guidelines for CVD risk assessment among persons with intermediate global risk scores 2). Coronary atherosclerotic
burden as measured by CAC correlates well with CVD
risk. In particular, persons with CAC scores (Agatston
Units) of zero have been shown to have very low mortality risk 3, 4).
Several lipoprotein subfractions have been demonstrated to be associated with atherosclerotic CVD
events including mortality. However, the role of lipoprotein subfractions in CVD risk assessment is still not
clearly defined particularly among relatively young (less
than 60 years) high cardiometabolic risk individuals.
Several studies have described a lipoprotein profile that
is thought to account for the most atherosclerotic CVD
risk 5). Although this atherogenic lipoprotein profile has
been demonstrated to be associated with CVD events,
the relationship between lipoprotein subclasses and noninvasive measures of coronary artery atherosclerosis such
as coronary artery calcium has only been examined by
a handful of studies. In most of these studies, even
though the relationship of individual lipoprotein subfractions are examined, their significant inter-correlation is often not accounted for and the combinations
identifying atherosclerosis risk is rarely examined.
In this study, we assessed the relationship between
individual lipoprotein subfractions, as measured by ion
mobility analysis, and coronary artery calcification in
a relatively young employee population with high cardiometabolic risk. First, we examined the association
of individual lipoprotein subfractions with the presence of CAC. Next, we explored combinations of lipoproteins, as identified in a principal component analysis, and their associations with CAC.
Methods
The Baptist Employee Healthy Heart Study is a

randomized trial comparing two internet based lifestyle interventions for weight reduction and promotion of cardiometabolic health. Participants were drawn
from the employee population of Baptist Health South
Florida (BHSF), a large not-for-profit health care organization in Miami, Florida. All study participants provided written informed consent. The study was approved
by the BHSF institutional review board (IRB) (IRB
13-028). This cross-sectional study presents findings
based on data collected at baseline.
Study Population
To be included in the study, participants had to
be current BHSF employees with high cardiometabolic risk as defined as having metabolic syndrome or
type Ⅱ diabetes mellitus. As per the National Cholesterol Education Program (NCEP) guidelines, metabolic
syndrome was defined as the presence of 3 or more of
the following: waist circumference ＞ 40 inches in men
and ＞ 35 inches in women; fasting triglyceride level
≥ 150 mg/dl or on treatment, HDL-C ＜ 40 mg/dl in
men or ＜50 mg/dl in women or on treatment, systolic
blood pressure ＞ 130 mmHg or diastolic blood pressure ＞ 85 mmHg or on treatment for hypertension and
fasting blood glucose ≥ 100 mg/dl or on antidiabetic
medication 6).
We excluded persons who had a previous diagnosis of CVD or a history of a CVD event such as angina,
myocardial infarction, prior coronary revascularization
or stroke. We also excluded persons with heart failure,
heart block, valvular disease, atrial fibrillation, and chronic obstructive pulmonary disease (COPD). Women
of child-bearing potential who were pregnant or seeking to become pregnant were also excluded, as were
women with a history of bilateral mastectomy. Subjects receiving active treatment for cancer or those
who had undergone a computerized tomography scan
of the chest within the last 1 year were also excluded.
Study Measurements
At baseline, all participants completed questionnaires on demographic and socioeconomic characteristics and lifestyle behaviors. The demographic information collected included age, sex, ethnicity, family
income, level of education and family size. Dietary
pattern was assessed using a modified version of a validated Mediterranean Diet questionnaire 7). Physical activity was assessed using the Global Physical Activity Ques-

Address for correspondence: Khurram Nasir, Section of Cardiovascular Medicine, Yale School of Medicine, Director Population Health & Health Systems Research,
Center for Outcomes Research and Evaluation, Yale University & Yale New Haven Health System, 1 Church St., Suite 200. New Haven, CT 06510, USA
E-mail: khurram.nasir@yale.edu
Received: April 3, 2017
Accepted for publication: April 15, 2018
Copyright©2019 Japan Atherosclerosis Society
This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.

51

Aneni et al .

Table 1. Demographic and clinical variables categorized by absence or presence of CAC
CAC (Agatston score)
[Median, IQR]

Total
(N = 170)

CAC = 0 (N = 88)
[0, 0 – 0]

CAC ＞ 0 (N = 82)
[55, 9 – 164]

Mean age (years)
% Female
Race
% Non-Hispanic White
% Hispanic (any color)
% Black
% Others
%HTN
%DM
%smoke
Mean (SD) BMI (kg/m2)
Median (IQR) Mets min/wk
Median (IQR) diet score

52 (10)
74

49 (10)
82

55 (8)
66

32.1
46.3
15.4
6.2
84.7
30.6
32.9
34.4 (6.2)
640 (0 – 2280)
6 (4 – 8)

28.1
47.2
19.1
5.6
81.8
22.7
19.3
34.2 (5.4)
600 (0 – 1800)
6 (4 – 8)

35.4
48.1
10.1
6.3
87.8
39.0
47.6
34.5 (6.9)
730 (240 – 3200)
6 (5 – 8)

P value
＜ 0.001

0.018
0.325

0.279
0.021
＜ 0.001
0.748
0.389
0.9098

CAC Coronary Artery Calcium; SD Standard Deviation; IQR Interquartile Range

tionnaire 8). Participants also responded to questions
on their past medical, social and family history.
All participants had their weights measured on a
calibrated weight scale, without shoes and with empty
pockets. Height was measured with a standardized scale
(Seca 213 Portable Stadiometer, Seca GmbH & Co.
KG, Hamburg, Germany) also without shoes. Participant abdominal circumference was measured using a
gulick measuring tape and according to the National
Institutes of Health (NIH) protocol. The gulick tape
was placed at a horizontal plane around the abdomen
at the level of the iliac crest with tension applied and
the measurement was taken at the end of expiration.
Blood pressure was measured in a seating position 5
minutes after rest following the guidelines of the American Heart Association 9).
Blood draw for laboratory samples for the lipoprotein analysis were conducted after an 8 hour fast.
At the study site, a total of about 28 mls of blood were
drawn in 5 tubes (2.7 mls in citrate plasma tube, 17
mls in 2 serum separator tubes and 8 mls in 2 ethylenediaminetetraacetate tubes). Samples for lipoprotein
subfraction analysis were centrifuged at room temperature (15-25 ℃) for 15 minutes at 3,000 rpm and aliquots of 1.5 mls of serum were placed in standard
transfer tubes. Aliquots were stored at −60 ℃ to −90 ℃
and shipped monthly to an American College of Pathology-certified laboratory (Quest Diagnostics Nichols
Institute, San Juan Capistrano, CA) on dry ice. Lipoprotein subfraction analysis was conducted using the
gas-phase differential electrical mobility (ion mobility)
analysis which directly quantifies the full spectrum of
lipoprotein particles. The ion mobility technique is
described elsewhere 10). This method has been validated
52

and used in several large scale cohort studies 11, 12). The
total cholesterol, HDL-C and triglycerides were measured by spectrophotometry, while the LDL-C was calculated using the Friedewald formula 13) unless triglyceride levels were greater than 400 mg/dl.
Participants who were above the age of 35 years
also had CT scan for coronary artery calcium quantification. Coronary arteries were scanned by non-contrast multi-detector row CT (acquisition time: 100 ms,
3 mm slice thickness) during the end-diastole. CAC
score was determined by the Agatston method 14).
Statistical Analysis
Nonparametric Spearman rank correlation coefficients were quantified for combinations of lipoproteins and lipids (HDL-C, LDL-C and triglycerides). A
principal component analysis was conducted for lipoprotein subfractions with and without the lipids for
170 individuals who had complete data on both lipoproteins and CAC. Principal component analysis is a
statistical procedure that transforms possibly correlated variables such as lipoprotein subfractions into
linear uncorrelated variables. This analyses effectively
reduces the dimensions of the data while preserving
most of the information within the data. Principal
component analysis is a statistical procedure that transforms possibly correlated variables such as lipoprotein
subfractions into linear uncorrelated variables. This
analyses effectively reduces the dimensions of the data
while preserving most of the information within the
data. Principal component analysis generates eigenvectors (often called principal component vectors) and
their corresponding eigenvalues (a measure of variance)
that are ranked in descending order of the amount of
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Table 2. Spearman correlation coefficients (ρ) for lipid and lipoprotein measures
HDL-C LDL-C
HDL-C
LDL-C
Trig
HDL-S

1.0

Trig

HDL-S HDL-L LDL-VS LDL-S LDL-M LDL-La LDL-Lb

0.18 a −0.29 c 0.30 d
1.0

0.05

0.25 b

1.0

0.08
1.0

HDL-L
LDL-VS
LDL-S

IDL-S

IDL-L VLDL-S VLDL-M VLDL-L

0.52 d −0.24 a −0.20 a

0.10

0.48 d

0.36 d

0.47 d 0.07

0.16 a

0.60 d

0.54 d

0.56 d

0.61 d 0.62 d

−0.01

0.75 d
1.0

0.19 a

0.38 d

0.47 d

0.44 d −0.02 −0.38 d −0.30 c −0.13

0.52 d

0.48 d

0.57 d

0.53 d

0.54 d

c

a

d

d

d

0.29
1.0

0.18

0.64

0.32

0.44

c

−0.02 −0.29 −0.30

c

0.55 d

0.22 b

0.09

0.34 d

0.52 d

0.84 d

0.83 d

0.64 d 0.61 d

0.53 d

0.38 c

0.08

0.22

0.12

0.62

d

0.44

d

0.39

d

0.79 d

0.62 d −0.05

0.00

0.16 a 0.50 d

0.50 d

0.57 d

0.42 d

1.0

0.69 d

0.07

0.23 d

0.29 c 0.62 d

0.55 d

0.53 d

0.37 d

1.0

0.67 d

0.82 d

0.64 d 0.60 d

0.44 d

0.23 d

0.08

LDL-M
LDL-La
LDL-Lb
IDL-S
IDL-L

1.0

0.95
1.0

d

0.85

d

0.39

c

0.79 d 0.44 d
1.0

0.70 d
1.0

VLDL-S

0.29 −0.09 −0.17 a
0.28 c −0.01 −0.15
0.55 d
0.90
1.0

VLDL-M
VLDL-L

d

0.17

0.00
d

0.41 d

0.80 d

0.62 d

1.0

0.92 d

0.62

1.0

a P ＜ 0.05, b P ＜ 0.01, c P ＜ 0.001, d P ＜ 0.0001

data variation explained. From the principal component vectors the coefficients of the linear transformation (loading values) for each individual within a principal component was computed. Principal component
scores for each individual were then calculated as the
summation of the product of the coefficients and the
particle concentration minus the lipid/lipoprotein subfraction mean for each lipid or subfraction 15). Supplementary Figs. 1-3 shows the scree and variance plots,
loading plots and the score plots. The scree plot is a
graph of the eigenvalues for each principal component
while the variance plot is a graph of the variance
explained by each principal component. The loading
plots show the contribution of each lipid /lipoprotein
subfractions to the principal components while the
score plot shows the contribution of each observation,
represented by a score, to each principal component.
We then bootstrapped our sample size of 170 to
5000 with replacement. Using an adjusted multivariate logistic regression analysis, the three principal components that accounted for the most variance were
then assessed for their relationship with CAC presence
(CAC ＞ 0). Similarly, the relationship of HDL-C, LDLC, triglycerides and each lipoprotein subfraction was
examined also adjusting for earlier outlined covariates.
The regression analysis of bootstrapping samples was

repeated 1000 times. The mean odds ratio (OR) and
the mean 95% confidence interval (CI), as well as the
frequency of a p value ＜ 0.05 are reported. Covariates
included in the regression analysis were age, sex, BMI,
hypertension, diabetes, diet-score, cigarette smoking,
non-HDL-C, physical activity. A statistical significance
level of alpha = 0.05 was chosen. Bootstrapping is a
statistical method in which the data is resampled with
replacement repeatedly generating multiple bootstrap
samples (in this case 5000) 16, 17). Considering that the
study sample size is small, a bootstrapped analysis is a
reliable way to increase power 16). Our method of conducting repeated regression analysis on bootstrapped
samples allows for more accurate estimates of statistical significance and has been used in previous studies 18). This method also provides for precise confidence
intervals 16).
All statistical analyses were conducted in STATA
version 12 (StataCorp LP, College Station, TX) 19) and
SAS version 9.4 (SAS Institute, Cary, NC) 20).
Results
A total of 182 participants were recruited at baseline and participated in this study. Of these, 12 participants, who were 35 years or younger and did not have
53
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Table 3. Comparisons of Lipid and Lipoprotein subclasses between Absence and Presence of CAC
Variable
LDL-C (mg/dl)
HDL-C (mg/dl)
Triglycerides (mg/dl)
HDL-S (nmol/L)
HDL-L (nmol/L)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)

CAC = 0
(N = 88)
128 (103 – 151)
47 (41 – 57)
124 (95 – 168)
415 (301 – 632)
266 (191 – 392)
286 (232 – 383)
297 (220 – 393)
247 (182 – 317)
224 (175 – 274)
200 (151 – 255)
6675 (5928 – 8301)
21655 (19962 – 25815)
71 (56 – 94)
56 (43 – 94)
16 (9 – 33)

CAC ＞ 0
(N = 82)
123 (96 – 143)
45 (40 – 54)
149 (109 – 206)
452 (343 – 686)
286 (211 – 362)
271 (220 – 349)
240 (183 – 348)
204 (163 – 301)
187 (149 – 256)
179 (147 – 242)
6290 (5700 – 7600)
20609 (18762 – 24192)
68 (52 – 85)
63 (36 – 85)
17 (8 – 30)

P value＊
0.096
0.245
0.065
0.352
0.742
0.279
0.022
0.051
0.026
0.247
0.090
0.075
0.293
0.819
0.700

All values are medians (interquartile ranges) unless otherwise stated.
LDL-C Low density lipoprotein cholesterol; LDL Low density lipoprotein; HDL-C High-density lipoprotein cholesterol;
HDL High-density lipoprotein cholesterol; IDL Intermediate-density lipoprotein, VLDL very-low-density lipoprotein;
＊
P value for nonparametric (Wilcoxon rank-sum test) comparison of continuous variables between binary groups

a CAC scan done, were excluded. The study population consisted of 170 participants with a mean age of
58 years, mostly female (84%) and with a high frequency of hypertension (85%). Participants with CAC
＞ 0 were older and had a higher frequency of males
and cigarette smokers. Diabetes was also more common among persons with CAC ＞ 0. More details about
population characteristics can be found in Table 1 and
in Supplementary Table 1. Description on the distribution of the lipid and lipoprotein particles are shown
in the box plots in Supplementary Fig. 4.
Table 2 shows the non-parametric spearman correlation coefficients (ρ) comparing lipids and lipoprotein subfractions to each other. The strongest correlations with triglycerides were the VLDL particles (ρ=
0.52, 0.84, 0.83 for the small, medium and large respectively). The very small and small LDL lipoproteins were
also strongly correlated with triglycerides (ρ= 0.47, 0.44).
Notably, the large LDL particles (subfractions a and b
respectively) were inversely correlated with triglycerides
(ρ=−0.38, −0.30) but were strongly correlated with
HDL-C (ρ= 0.48, 0.36), and with both the small HDL
(ρ= 0.53, 0.54) and large HDL (ρ= 0.32, 0.44) lipoprotein particles. The strongest correlations of the HDL-C
were with the HDL-L (ρ= 0.52), both subfractions of
LDL large (0.48, 0.36 for a and b respectively) and
IDL-S (ρ= 0.47). In non-parametric correlation analysis (spearman’s), triglycerides were weakly positively
correlated with CAC, while HDL lipoprotein subfrac54

tions and the large LDL lipoprotein subfractions were
negatively correlated with CAC, albeit weakly (Supplementary Table 2)
Table 3 shows the median lipid and lipoprotein
particle concentrations for those with CAC = 0 and CAC
＞ 0. Higher concentrations of large LDL were seen
among those with no CAC. Persons without CAC also
had lower triglyceride and higher HDL particle concentrations, though statistical comparisons show that
these differences were only marginally significant. In
trend analyses comparing median lipoprotein subclasses
across groups of CAC = 0, CAC = 1-99 and CAC = 100
or more (Supplementary Table 3), there was a trend
to increasing median triglycerides and decreasing large
LDL subfractions and decreasing HDL lipoprotein
subfractions with increasing CAC.
Results of the principal component (PC) descriptions are shown in Table 4 and are graphically described
in the Supplementary Figs. 1-3. As shown in the scree
and variance plots (Supplementary Fig. 1) and in Table
4, the first three principal components accounted for
more than 80% of the variance in the data. The contributions to PC1 were more evenly split across lipoprotein particle groups with slightly greater contributions from the small and medium LDL particles, the
small and large IDL particles and the small VLDL
particles. The major contributions of PC2 were VLDL
particle in the positive direction and the large LDL
particles in the negative direction, while PC3 repre-
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Table 4. Description of Principal Components
Measure
LDL-C (mg/dl)
HDL-C (mg/dl)
Triglycerides (mg/dl)
HDL-S (nmol/L)
HDL-L (nmol/L)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)
% Variance

Principal Components with Lipoprotein only

Principal Components with Lipoproteins and Lipids

PC1

PC2

PC3

PC1＋

PC2＋

PC3＋

−

−

−

＋0.213

−0.117

−0.451

−

−

−

＋0.039

−0.337

＋0.468

−

−

−

＋0.115

＋0.448

＋0.187

＋0.315

−0.167

＋0.387

＋0.288

−0.143

＋0.321

＋0.269

−0.152

＋0.602

＋0.244

−0.207

＋0.497

＋0.276

＋0.273

−0.064

＋0.265

＋0.225

＋0.093

＋0.308

＋0.111

−0.451

＋0.297

＋0.155

−0.177

＋0.312

−0.174

−0.436

＋0.309

−0.074

−0.266

＋0.240

−0.437

＋0.064

＋0.241

−0.352

−0.063

＋0.266

−0.390

−0.185

＋0.270

−0.278

−0.199

＋0.319

−0.240

＋0.179

＋0.304

−0.225

−0.266

＋0.345

＋0.122

−0.436

＋0.336

＋0.063

＋0.005

＋0.325

＋0.233

−0.003

＋0.321

＋0.154

−0.081

＋0.271

＋0.397

＋0.045

＋0.264

＋0.323

＋0.009

＋0.175

＋0.468

＋0.203

＋0.179

＋0.384

＋0.153

58.8

21.4

7.3

51.6

22.8

7.8

sents HDL lipoprotein particles in the positive direction and small and medium LDL particles as well as
large IDL particles in the negative direction. Addition
of HDL-C, LDL-C and triglycerides altered the contribution of the large IDL to PC3 but did not significantly alter the other PC patterns. The loading plots
(Supplementary Fig. 2) show the relative lipoprotein
contributions and their directions as described above.
In multivariate boot-strapped analysis, controlling for earlier mentioned covariates, there was no association between PC1 and the presence of CAC. PC2
was associated with a 22% increase in the odds of
CAC (OR 1.22, 95% CI: 1.17-1.27, p ＜0.05 in 100%
of boot-strapped analysis) while PC3 showed a modest but significant reduction in CAC odds (OR 0.91,
95% CI: 0.85-0.97, p ＜ 0.05 in 88% of boot-strapped
analysis). Analysis of the cholesterol and lipoprotein
particles showed that the large LDL particles were protective of CAC, and the small and medium LDL were
associated with greater odds for the presence of CAC.
Notably, LDL-C did not show an association with CAC.
Discussion
In this study of 170 relatively young individuals
with high cardiometabolic risk, two of the three principal component axes (accounting for about 88% of
the variance) of lipoprotein distribution were associated with the presence of CAC, even after controlling
for traditional cardiovascular risk factors. Although PC1
accounted for nearly 60% of the variance, PC1 did not

exhibit much variation in lipoprotein subclasses and
was not associated with CAC. Each SD increase in PC2,
representing decreased medium and large LDL lipoprotein particles, increased VLDL and small LDL lipoprotein particles, and increased triglycerides, was associated with a 22% increase in the odds of CAC. On
the other hand, a each SD increase in PC3, a combination of increasing small and large HDL particles and
decreasing small and medium LDL particles, was associated with a 9% reduction in the odds of CAC. Musunuru and colleagues, using a principal component analyses method in the Malmö diet and Cancer-Cardiovascular Cohort (MDC-CC) demonstrated that a pattern with increased small and medium LDL particle
concentrations, decreased large HDL particle concentrations and increased triglyceridemia (referred to as atherogenic dyslipidemia) 12, 21). PC2's profile is similar to
the atherogenic lipoprotein profile described by Musunuru et al., a profile demonstrated to be associated with
increased atherosclerotic cardiovascular disease mortality risk 22).
A previous study, using the concept of a principal
component analysis, identified three separate axes of
cardiovascular risk. In that study, the authors demonstrated that a principal component axis that comprised
mainly of contributions from increasing VLDL and
LDL particles, as well as another PC axis in which small
and medium LDL particles combined with diminishing (negative direction) large HDL, was associated with
increased risk of CV events 12). In a separate study, a
PC axis characterized by contributions from VLDL in
55
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Table 5. Boost Strapped Analysis for Odds ratio of CAC
Principal Components
PC 1
PC 2
PC 3
HDL-C (mg/dl)
LDL-C (mg/dl)
Triglycerides (mg/dl)
HDL-S (nmol/L)
HDL-L (nmol/L)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)

Boot Strapped N

Mean Adjusted OR (95% CI)
per SD increase

% with P ＜ 0.05

5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000
5000

1.01 (0.98, 1.03)
1.22 (1.17, 1.27)
0.91 (0.85, 0.97)
0.75 (0.70, 0.81)
0.99 (0.98, 1.06)
1.27 (1.18, 1.36)
0.92 (0.89, 0.99)
0.89 (0.83, 0.95)
1.46 (1.35, 1.48)
1.20 (1.11, 1.28)
1.00 (0.93, 1.07)
0.75 (0.70, 0.81)
0.83 (0.77, 0.89)
0.85 (0.79, 0.91)
1.16 (1.08, 1.26)
1.21 (1.12, 1.31)
1.19 (1.10, 1.28)
1.00 (0.93, 1.07)

4
100
88.4
100
5.9
100
65.9
95.5
100
100
2
100
100
99.1
99.1
100
99.8
3.6

Sample bootstrapped to size of 5000. Regression analysis conducted 1000 times. OR and CIs is calculated as the mean of OR and
their upper and lower CI limits from 1000 bootstrapped analysis.
% with P ＜ 0.05 is the frequency of OR that have P ＜ 0.05 out of analysis conducted 1000 times.
Controlled for age, sex, blood pressure, presence of diabetes, cigarette smoking, diet and physical activity. All lipoproteins were
included in regression models for the individual lipoproteins.

the positive direction and large LDL particles in the
negative direction was associated with incident CAC
in persons with CKD 23). Our study showed similar
results with the aforementioned studies, with an axis
of CAC risk defined by the combination of VLDL
particles and diminishing large LDL particles (i.e. in
the negative direction). We also demonstrated modest
protection with a PC axis that combined increasing
HDL particles with diminishing LDL particles. In a
search of the published literature, we did not find any
other studies that had examined lipoproteins and their
association with CAC in terms of axis of risk in relatively young patients with high cardiometabolic risk
but otherwise healthy.
PC2 represents an axis of risk that is characterized by high triglyceride rich lipoproteins (TGRL) i.e.
VLDL combined with low levels of large LDL particles. TGRLs are proinflammatory, leading to atherosclerosis by pathways that involve the upregulation of
TNF-alpha, induction of vascular cell adhesion molecules (VCAM) and promotion of monocyte infiltration of the vessel wall 24). TGRLs have been associated
with risk of ASCVD, ASCVD-related mortality and
all-cause mortality 25). Elevated VLDL has also been
associated with the presence of CAC in both diabetic
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and non-diabetic individuals 26). In contrast, HDL lipoprotein exerts its anti-atherogenic effect through exertion multiple anti-oxidant mechanisms and promotion of efflux of excess cholesterol from foam cells in
the arterial wall 27). Thus, it is conceivable that a lipoprotein profile predominated by increased HDL particles appears protective of CAC.
Ion mobility analysis for the subfractionation of
lipoproteins employs a gas-phase chromatography system that directly counts the lipoprotein particles 10). Lipoprotein subfractionation using the ion mobility analysis has been used in other large studies 11, 12) and holds
the advantage of directly assessing particle counts without the use of an algorithm 10). To our knowledge, this
is the first study using ion-mobility analysis that identifies CAC risk by lipoprotein profile.
As noted in the results, the individual lipoprotein
subfractions are correlated in varying degrees both
within classes (e.g. HDL lipoprotein subfractions being
correlated) and between classes (e.g. HDL lipoprotein
subfractions with LDL subfractions, Table 3). Therefore, analysis of individual subfractions without context to the others poses a dilemma with interpretation
of results (Table 2). To circumvent this, we conducted
principal component analyses. Principal component
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analysis has the advantage of showing several patterns
of lipoprotein distributions. Therefore, it provides information on the distribution of lipoproteins relative to
each other making assessments of the entire distribution and not just individual lipoproteins feasible. PC
analysis is widely used when there are multiply-correlated data as is seen in lipoprotein subfraction tests
(Table 2). PC analysis in the assessment of lipoprotein
distribution and their risk of CV outcomes is not unique
to this study 12, 23). For instance, Musunuru and colleagues employed a PC analysis in the assessment of
lipoprotein profiles and their risk of cardiovascular and
all-cause mortality 12). However, this is the first study to
use a PC analysis of lipoprotein subfractions to assess
CAC risk in a relatively young high-risk population.
Our study has some notable limitations. The sample size of 170 is limited in power to determine small
statistical differences particularly when several covariates are included in the regression model. To overcome
this, we performed a boot-strapped analysis to create
5000 samples with replacement to eliminate the problems of sample size and conducted the boot-strapping
regression analyses 1000 times to improve precision.
Nonetheless, our findings can only be interpreted in
the context of the population studied, thus limiting its
generalizability. Our lack of temporal data precludes
comments or conclusions on lipoproteins and causality or progress of CAC.
In conclusion, PC analysis of lipoprotein subfractions measured by ion-mobility testing identified at
least 2 axes of CAC risk in this relatively young, high
cardiometabolic risk population. A lipoprotein profile
dominated by high TGRLs such VLDL and low in
large LDL particles was associated with elevated CAC
risk, while a profile that was high in HDL lipoproteins
and low in small and medium lipoproteins conferred
modest protection from CAC. In contrast, LDL-C
alone was not associated with CAC. Thus, in a population regarded as high risk, a simple blood test such
as lipoprotein sub-fraction analysis, may help to further discriminate patients who will require more intensive cardiovascular work-up and treatment.
Conflicts of Interest and
Funding Declaration
Dr Nasir is on the advisory board for Quest Diagnostics and is a consultant for Regeneron. No other
potential conflicts of interest relevant to this article were
reported. This research was partially funded by Quest
Diagnostics Incorporated, USA.

References
1) Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection
of High-Risk Young Adults and Women by Coronary
Calcium and National Cholesterol Education Program
Panel III Guidelines. J Am Coll Cardiol, 2005; 46: 19311936
2) Goff DC, Lloyd-Jones DM, Bennett G, Coady S,
D’Agostino RB, Gibbons R, Greenland P, Lackland DT,
Levy D, O’Donnell CJ, Robinson J, Schwartz JS, Shero ST,
Smith SC, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC/
AHA Guideline on the Assessment of Cardiovascular Risk
A Report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines. Circulation, 2013 Nov 12; 01.cir.0000437741.48606.98
3) Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA,
Berman D, Callister T, Raggi P, Blumenthal RS, Nasir K.
Absence of Coronary Artery Calcification and All-Cause
Mortality. JACC Cardiovasc Imaging, 2009; 2: 692-700
4) Valenti V, Ó Hartaigh B, Heo R, Cho I, Schulman-Marcus J, Gransar H, Truong QA, Shaw LJ, Knapper J,
Kelkar AA, Sandesara P, Lin FY, Sciarretta S, Chang H-J,
Callister TQ, Min JK. A 15-Year Warranty Period for
Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals.
JACC Cardiovasc Imaging, 2015; 8: 900-909
5) Carmena R, Duriez P, Fruchart J-C. Atherogenic Lipoprotein Particles in Atherosclerosis. Circulation, 2004;
109 (23 suppl 1): III-2-III-7
6) National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III).
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) final report. Circulation,
2002; 106: 3143-3421
7) Martínez-González MA, García-Arellano A, Toledo E,
Salas-Salvadó J, Buil-Cosiales P, Corella D, Covas MI,
Schröder H, Arós F, Gómez-Gracia E, Fiol M, RuizGutiérrez V, Lapetra J, Lamuela-Raventos RM, SerraMajem L, Pintó X, Muñoz MA, Wärnberg J, Ros E,
Estruch R, Investigators for the PS. A 14-Item Mediterranean Diet Assessment Tool and Obesity Indexes among
High-Risk Subjects: The PREDIMED Trial. PLOS ONE,
2012; 7: e43134
8) Armstrong T, Bull F. Development of the World Health
Organization Global Physical Activity Questionnaire
(GPAQ). J Public Health, 2006; 14: 66-70
9) Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J,
Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ.
Recommendations for Blood Pressure Measurement in
Humans and Experimental Animals Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals from the Subcommittee of Professional and Public
Education of the American Heart Association Council on
High Blood Pressure Research. Hypertension, 2005; 45:
142-161
10) Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA,
Benner WH, Reitz RE, Krauss RM. Direct Determination of Lipoprotein Particle Sizes and Concentrations by
57

Aneni et al .

Ion Mobility Analysis. Clin Chem, 2008; 54: 1307-1316
11) Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko
HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM.
Atherogenic Lipoprotein Subfractions Determined by Ion
Mobility and First Cardiovascular Events After Random
Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial. Circulation, 2015; 132: 2220-2229
12) Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE, Berglund G, Hedblad B, Engström
G, Williams PT, Kathiresan S, Melander O, Krauss RM.
Ion mobility analysis of lipoprotein subfractions identifies
three independent axes of cardiovascular risk. Arterioscler
Thromb Vasc Biol, 2009; 29: 1975-1980
13) Friedewald WT, Levy RI, Fredrickson DS. Estimation of
the concentration of low-density lipoprotein cholesterol
in plasma, without use of the preparative ultracentrifuge.
Clin Chem, 1972; 18: 499-502
14) Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR,
Viamonte M, Detrano R. Quantification of coronary
artery calcium using ultrafast computed tomography. J
Am Coll Cardiol, 1990; 15: 827-832
15) Lindsay I Smith. A tutorial on Principal Components
Analysis, 2002
16) Resampling methods: concepts, applications, and justification. Yu, Chong Ho [Internet]. [cited 2016 Jun 17].
Available from: http://pareonline.net/getvn.asp?v=8&n=19
17) Efron B. Bootstrap Methods: Another Look at the Jackknife. Ann Stat, 1979; 7: 1-26
18) Dai J, Su Y-X, Bartell S, Le N-A, Ling W-H, Liang Y-Q,
Gao L, Wu H-Y, Veledar E, Vaccarino V. Beneficial effects
of designed dietary fatty acid compositions on lipids in
triacylglycerol-rich lipoproteins among Chinese patients

58

with type 2 diabetes mellitus. Metabolism, 2009; 58: 510518
19) Stata Statistical Software: Release 12. College Station,
Texas: StataCorp LP; 2011
20) SAS Statistical Software: Version 9.4. Cary, NC: SAS
Institute; 2013
21) Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic
marker for coronary heart disease risk. Circulation, 1990;
82: 495-506
22) Musunuru K. Atherogenic Dyslipidemia: Cardiovascular
Risk and Dietary Intervention. Lipids, 2010; 45: 907-914
23) Lamprea-Montealegre JA, McClelland RL, Astor BC,
Matsushita K, Shlipak M, Boer IH de, Szklo M. Chronic
Kidney Disease, Plasma Lipoproteins, and Coronary
Artery Calcium Incidence: The Multi-Ethnic Study of
Atherosclerosis. Arterioscler Thromb Vasc Biol, 2013; 33:
652-658
24) Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S,
Gaudet D. Genetics and Causality of Triglyceride-Rich
Lipoproteins in Atherosclerotic Cardiovascular Disease. J
Am Coll Cardiol, 2014; 64: 2525-2540
25) Nordestgaard BG. Triglyceride-Rich Lipoproteins and
Atherosclerotic Cardiovascular Disease New Insights from
Epidemiology, Genetics, and Biology. Circ Res, 2016;
118: 547-563
26) Colhoun HM, Otvos JD, Rubens MB, Taskinen MR,
Underwood SR, Fuller JH. Lipoprotein Subclasses and
Particle Sizes and Their Relationship with Coronary
Artery Calcification in Men and Women with and Without Type 1 Diabetes. Diabetes, 2002; 51: 1949-1956
27) Natarajan P, Ray KK, Cannon CP. High-Density Lipoprotein and Coronary Heart DiseaseCurrent and Future
Therapies. J Am Coll Cardiol, 2010; 55: 1283-1299

Lipoprotein Subfractions and CAC

Supplementary Fig. 1. Scree and Variance Plots of Principal Components
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Supplementary Fig. 2. Loading plots for PC 1, PC 2 and PC 3
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Supplementary Fig. 3. Score plots for PC 1, PC 2 and PC 3

Supplementary Table 1. Demographic data across three CAC groups
Variable
Mean age (SD, years)
% Female
Race
% Non-Hispanic White
% Hispanic (any color)
% Black
% Others
%HTN
%DM
%Smoke
Mean (SD) BMI (kg/m2)
Median (IQR) Mets min/wk
Median (IQR) diet score

CAC = 0
(N = 88)

CAC 1-99
(N = 50)

CAC 100＋
(N = 32)

49 (10)
82

53 (9)
64

58 (7)
69

28.9
44.6
20.5
5.6
81.8
22.7
6.8
34.2 (5.4)
600 (0 – 1800)
6 (4 – 7)

34.0
48.9
10.6
8.2
84.0
36.0
19.0
34.8 (7.1)
840 (240 – 3840)
7 (4 – 8)

37.5
46.9
9.4
6.3
93.9
43.8
50.0
34.2 (6.6)
610 (120 – 1740)
5 (5 – 8)

P trend
＜ 0.001

0.067
0.734

0.272
0.053
0.826
0.921
0.686
0.774
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Supplementary Fig. 4. Box plots of lipoprotein subclasses

Supplementary Table 2. Correlation of CAC with Lipids and Lipoprotein subfractions
Lipid/Lipoprotein particle
HDL-c (mg/dL)
LDL-c (mg/dL)
Triglycerides (mg/dL)
HDL-S (nmol/L)
HDL-L (nmol/L)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)

62

idllarge

1,500

40,000

idlsmall

Spearman’s coefficient (rho)
−0.1339
−0.1106

0.1828
−0.1492
−0.1583

0.0993
0.0520
−0.0872
−0.2010
−0.1704
−0.1685
−0.0597
−0.0269
0.0311
0.0136

P Value
0.087
0.160
0.0188
0.052
0.039
0.214
0.5004
0.2584
0.0086
0.0263
0.0281
0.4396
0.7282
0.6876
0.8606
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Supplementary Table 3. Relationship CAC and Lipoproteins
Variable

CAC = 0
(N = 88)

CAC 1-99
(N = 50)

CAC 100＋
(N = 32)

P trend

LDL-c (mg/dL)
HDL-c (mg/dL)
Triglycerides (mg/dL)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
HDL-L (nmol/L)
HDL-S (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)

128 (103 – 151)
47 (41 – 57)
124 (95 – 168)
415 (301 – 632)
266 (191 – 392)
286 (232 – 383)
270 (220 – 393)
247 (182 – 317)
224 (175 – 274)
200 (151 – 255)
6675 (5928 – 8301)
21655 (19962 – 25815)
71 (56 – 94)
56 (43 – 94)
16 (9 – 33)

115 (97 – 140)
48 (41 – 54)
140 (92 – 172)
402 (341 – 592)
258 (203 – 322)
262 (220 – 356)
253 (183 – 353)
223 (163 – 301)
186 (144 – 259)
177 (141 – 214)
6345 (5700 – 7880)
20832 (18570 – 24913)
61 (48 – 81)
56 (32 – 76)
15 (6 – 27)

123 (98 – 142)
42 (38 – 49)
164 (118 – 237)
506 (352 – 749)
311 (217 – 410)
278 (222 – 357)
231 (184 – 330)
197 (157 – 283)
192 (159 – 243)
190 (163 – 251)
6142 (5597 – 7340)
20449 (18266 – 23961)
70 (59 – 86)
68 (43 – 91)
21 (11 – 35)

0.172
0.065
0.016
0.126
0.217
0.413
0.013
0.036
0.036
0.771
0.047
0.047
0.825
0.548
0.685
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